Radium 223 (Xofigo) is a new advanced prostate cancer treatment that uses a low level of targeted radiation to kill cancer cells. Dr. Neil Shore, a prostate cancer expert, explains the safety of this approach.
This content was provided by the Patient Empowerment Network, which received an unrestricted educational grant from Bayer Oncology.
Loading more stuff…
Hmm…it looks like things are taking a while to load. Try again?